Atsuko Ogino

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also affiliated with Harvard University, Dana-Farber Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer”.

An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer

Nature Cancer(2022)10.1038/s43018-022-00351-8

N/A

0DataRank · unranked

163 citations

Tyler S. Beyett, Jaebong Jang, William W. Feng, Magda Bahcall, Heidi M. Haikala +21 more

MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer

Cancer Cell(2022)10.1016/j.ccell.2022.08.015

N/A

0DataRank · unranked

102 citations

Tetsuo Tani, Benjamin F. Springer, Marco Campisi, Tatsuya Osaki, Koji Haratani +23 more